ASBrS Input Needed on Endocrine Therapy Resource Guide
The ASBrS has revised and updated the document A Surgeon’s Resource Guide to Endocrine Therapy for the Management and Risk Reduction of Hormone Receptor Positive Breast Cancer. ASBrS will post drafts of consensus statements, resource guides, clinical pathways, and other documents for public comment before they are finalized and sent to the Board of Directors for final approval.
To review the revised statement and provide comment, please click here.
All comments must be submitted by February 2, 2024.
The public comment period is an integral part of the development process and is preceded by a series of reviews and revisions and may be followed by a final peer review if the document is submitted to a journal for publication. ASBrS encourages our members and colleagues to comment. Please share this with your colleagues to help produce a more robust public response.
An ASBrS Resource Guide is an expert opinion document on a topic. The Guide reflects the consensus of a panel, with the approval of the Board of Directors, and is based on multiple sources from peer-reviewed literature. A systematic review of the literature is not performed.